In addition, the difference in GFAP levels between human PD patients and LRRK2 G2019Ski/ki mice reflects the complexity of human PD pathology, the limitations of single-gene mouse models, and potential species-specific differences in astrocyte reactivity. Here, GFAP is linked to Parkinson disease.